This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.89% per year. These returns cover a period from January 1, 1988 through March 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
ad-tech: Archive
UiPath (PATH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PATHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Shockingly Low-Budget DeepSeek Upends AI Ecosystem But Could Bear Bullish Implications
by Mayur Thaker
Lower cost competition should be something to cheer, not fear.
NVDAPositive Net Change ASMLNegative Net Change LRCXNegative Net Change AVGONegative Net Change TSMPositive Net Change
ad-tech
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VORNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bull of the Day: AppLovin Corporation (APP)
by Benjamin Rains
AppLovin (APP) stock has been a Wall Street superstar over the last two years, soaring 3,000% to blow away Nvidia and most other artificial intelligence stocks. APP stock has traded sideways for the past two months and looks due to break out to all-time highs.
NVDAPositive Net Change APPPositive Net Change METAPositive Net Change
ad-tech advertising artificial-intelligence tech-stocks
Lovin' That App: Can This Momentum Stock Continue Higher After 712% Run?
by Bryan Hayes
There's been a lot of chatter about APP stock potentially slowing, but earnings estimates are on the rise.
APPPositive Net Change
ad-tech advertising artificial-intelligence earnings gaming investing mobile software tech-stocks
Adidas AG (ADDYY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADDYYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can the Sincera Buyout Change TTD's Fate or is it Still a Risky Bet?
by Nida Ali Saigal
TTD is benefiting from an innovative portfolio and a rich partner base. However, a stretched valuation and fierce competition pose concerns.
DISPositive Net Change TTDPositive Net Change ROKUPositive Net Change SPOTNegative Net Change
ad-tech advertising tech-stocks television
Trump Inauguration Comes with Optimism Of Economy, Markets and Earnings
by Mayur Thaker
Lots of reasons to be bullish, but the key is to enforce risk management rules.
UPSNegative Net Change
ad-tech
After Golden Cross, Coterra Energy (CTRA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CTRANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, USA Compression Partners (USAC)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
USACNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Plains All American Pipeline (PAA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PAANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
December Jobs Report Significant Reversal of Bearish Trends, Sending Yields Roaring Higher
by Mayur Thaker
There's a lot to be excited about, but two major risks persist in today's market.
DFSNegative Net Change COFNegative Net Change AXPPositive Net Change
ad-tech
Here's Why ROKU Stock is a Strong Buy Despite 8% Decline in a Year
by Zacks Equity Research
Roku's innovation, partnerships and growing user base drive its strong prospects, making it a standout buy despite the stock's dip over the past year.
FOXAPositive Net Change GAIANegative Net Change ROKUPositive Net Change FUBONegative Net Change
ad-tech consumer-discretionary
Arc Resources (AETUF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AETUFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Phreesia (PHR) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PHRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Markets Coasting As Traders Await Policy Clarity, Q4 Earnings And 2025 Guidance
by Mayur Thaker
Equity markets are entering the new year, new administration with high expectations, and high risks.
DFSNegative Net Change COFNegative Net Change AXPPositive Net Change
ad-tech apparel
Braze, Inc. (BRZE) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BRZEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why You Should Be Cautious With iQIYI Stock Heading Into 2025
by Zacks Equity Research
IQ is struggling with intense competition and declining ad revenues, despite an innovative content portfolio and expanding global reach.
TCEHYNegative Net Change BABAPositive Net Change BILIPositive Net Change IQNegative Net Change
ad-tech artificial-intelligence communications consumer-discretionary
Innovid Up 70% in the Past 6 Months: Should Investors Buy the Stock?
by Zacks Equity Research
CTV benefits from strong growth in connected TV advertising, ongoing collaborations with major streaming platforms and expanding AI-driven capabilities.
NFLXPositive Net Change DISPositive Net Change GOOGLNegative Net Change
ad-tech internet tech-stocks
Is The Trade Desk Stock a Buy, Sell or Hold at its P/S of 20.78X?
by Nida Ali Saigal
TTD shares are riding on an innovative portfolio and rich partner base, though stretched valuation and fierce competition pose concerns.
DISPositive Net Change TTDPositive Net Change ROKUPositive Net Change SPOTNegative Net Change
ad-tech artificial-intelligence tech-stocks
More & More Regulations Under Trump: How Will Tech Giants Cope in 2025?
by Zacks Equity Research
In Trump's second term, tech giants like GOOGL, MSFT, META and AAPL face tough regulations on AI, antitrust and privacy.
AAPLPositive Net Change MSFTPositive Net Change GOOGLNegative Net Change METAPositive Net Change
ad-tech artificial-intelligence cloud-computing tech-stocks
BILI Shares Rise 59% Year to Date: Should Investors Buy the Stock?
by Zacks Equity Research
Bilibili is benefiting from strong ad growth, boosted gaming revenues and increased user engagement.
TCEHYNegative Net Change BILIPositive Net Change IQNegative Net Change HUYAPositive Net Change
ad-tech social-media tech-stocks
ReNew Energy Global PLC (RNW)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
RNWNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy VinFast Auto Ltd. (VFS) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VFSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
KLA's Shares Plunge 14% in 3 Months: Should You Buy, Sell or Hold?
by Zacks Equity Research
KLAC's growing portfolio bodes well. However, rising debt and stiff competition pose near-term challenges, making the stock a risky bet.
KLACNegative Net Change FLUXPositive Net Change SESNegative Net Change SDSTPositive Net Change
ad-tech tech-stocks